Publicação
Diversity of Bioactive Compounds in Microalgae
| Resumo: | Microalgae offer a sustainable and versatile source of bioactive compounds. Their rapid growth, efficient CO2 utilization, and adaptability make them a promising alternative to traditional production methods. Key compounds, such as proteins, polyunsaturated fatty acids (PUFAs), polyphenols, phytosterols, pigments, and mycosporine-like amino acids (MAAs), hold significant commercial value and are widely utilized in food, nutraceuticals, cosmetics, and pharmaceuticals, driving innovation across multiple industries. Their antiviral and enzyme-producing capabilities further enhance industrial and medical applications. Additionally, microalgae-based biostimulants and plant elicitor peptides (PEPs) contribute to sustainable agriculture by enhancing plant growth and resilience to environmental stressors. The GRAS status of several species facilitates market integration, but challenges in scaling and cost reduction remain. Advances in biotechnology and metabolic engineering will optimize production, driving growth in the global microalgae industry. With increasing consumer demand for natural, eco-friendly products, microalgae will play a vital role in health, food security, and environmental sustainability. |
|---|---|
| Autores principais: | Osathanunkul, Maslin |
| Outros Autores: | Thanaporn, Suebsuya; Karapetsi, Lefkothea; Nteve, Georgia Maria; Pratsinakis, Emmanouil; Stefanidou, Eleni; Lagiotis, Giorgos; Avramidou, Eleni; Zorxzobokou, Lydia; Tsintzou, Georgia; Athanasiou, Artemis; Mpelai, Sofia; Constandinidis, Constantinos; Pantiora, Panagiota; Merino, Marián; Mullor, José Luis; Dobrovic, Luka; Cerasino, Leonardo; Ogawa, Tomohisa; Tsaousi, Meropi; Rodrigues, Alexandre M. C.; Cardoso, Helena; Pires, Rita; Figueiredo, Daniel; Costa, Inês F.; Anjos, Catarina; Labrou, Nikolaos E.; Madesis, Panagiotis |
| Assunto: | Biomass Carbon dioxide utilization Cosmeceuticals Food supplements Pharmaceuticals Pharmaceutical Science Drug Discovery Pharmacology, Toxicology and Pharmaceutics (miscellaneous) SDG 2 - Zero Hunger SDG 9 - Industry, Innovation, and Infrastructure SDG 13 - Climate Action |
| Ano: | 2025 |
| País: | Portugal |
| Tipo de documento: | recensão |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| Resumo: | Microalgae offer a sustainable and versatile source of bioactive compounds. Their rapid growth, efficient CO2 utilization, and adaptability make them a promising alternative to traditional production methods. Key compounds, such as proteins, polyunsaturated fatty acids (PUFAs), polyphenols, phytosterols, pigments, and mycosporine-like amino acids (MAAs), hold significant commercial value and are widely utilized in food, nutraceuticals, cosmetics, and pharmaceuticals, driving innovation across multiple industries. Their antiviral and enzyme-producing capabilities further enhance industrial and medical applications. Additionally, microalgae-based biostimulants and plant elicitor peptides (PEPs) contribute to sustainable agriculture by enhancing plant growth and resilience to environmental stressors. The GRAS status of several species facilitates market integration, but challenges in scaling and cost reduction remain. Advances in biotechnology and metabolic engineering will optimize production, driving growth in the global microalgae industry. With increasing consumer demand for natural, eco-friendly products, microalgae will play a vital role in health, food security, and environmental sustainability. |
|---|